$GRF News

Assessing Grifols (BME:GRF) Valuation After Recent Share Price Weakness And Perceived Discount

Is Grifols (BME:GRF) Offering Value After Recent Share Price Swings?

Green Rise Announces Certain Management Changes

Green Rise Foods Announces Q3 Fiscal 2025 Financial Results

Eagle Capital Growth Fund Declares Year-End Distribution of $0.85 Per Share in Cash

Eagle Capital Growth Fund Declares Year-End Distribution of $0.68 Per Share in Cash

Grifols price target lowered to EUR 15.50 from EUR 15.60 at Berenberg

Grifols receives FDA approval to treat surgical bleeding with FS solution

Green Rise Capital Corp. Reports Strong Q3 Growth

Grifols partners with BARDA for PoC testing of ocular immunoglobulin

GigaGen Receives FDA Clearance of IND Application for Phase 1 Trial of Recombinant Polyclonal for HBV Treatment, GIGA-2339

Grifols Trading Suspension Lifted by NSMC

Grifols Reports Robust H1 2024 Financial Growth

Grifols Announces Financial Restatements; Results Stand Firm

Grifols S.A. Trading Suspended Amidst Information Withholding

Grifols receives expanded XEMBIFY? (immune globulin subcutaneous human-klhw) label in U.S., strengthening its Ig portfolio for patients

Grifols Prepares for Potential Acquisition Offer

Grifols Strengthens Financial Position for 2024

Grifols completes sale of a 20% equity stake in SRAAS and forges strategic alliance with Haier Group

Grifols Concludes $1.8 Billion Stake Sale to Haier